The role of PARP1 in neurodegenerative diseases and aging
Open accessAbstract
Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by progressive memory loss and motor impairment. Aging is a major risk factor for neurodegenerative diseases. Neurodegenerative diseases and aging often develop in an irreversible manner and cause a significant socioeconomic burden. When considering their pathogenesis, many studies usually focus on mitochondrial dysfunction and DNA damage. More recently, neuroinflammation, autophagy dysregulation, and SIRT1 inactivation were shown to be involved in the pathogenesis of neurodegenerative diseases and aging. In addition, studies uncovered the role of poly (ADP‐ribose)‐polymerase‐1 (PARP1) in neurodegenerative diseases and aging. PARP1 links to a cluster of stress signals, including those originated by inflammation and autophagy dysregulation. In this review, we summarized the recent research progresses on PARP1 in neurodegenerative diseases and aging, with an emphasis on the relationship among PARP1, neuroinflammation, mitochondria, and autophagy. We discussed the possibilities of treating neurodegenerative diseases and aging through targeting PARP1.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased PARP1 activation and elevated poly(ADP-ribose) are observed in numerous neurodegenerative disorders and their associated animal models.
“Increased PARP1 activation and elevated poly(ADP‐ribose) has been observed in numerous neurodegenerative disorders and their associated animal models (Thapa et al, 2021; Mao & Zhang 2022).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Mao & Zhang 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · see citing works
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Amé, J., & de MURCIA, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,917 · see citing works
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242 · see citing works
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837 · see citing works
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836 · see citing works
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · see citing works
Regulation of SIRT1 in cellular functions: Role of polyphenols
Chung, S., Yao, H., Caito, S. W., Hwang, J., Arunachalam, G., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.003 · Cited by 651 · see citing works
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601 · see citing works
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588 · see citing works
Poly(ADP-ribose) polymerase inhibition: past, present and future
Curtin, N. J., & Szabó, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 576 · see citing works
Fang, E. F., Kassahun, H., Croteau, D. L., Scheibye-Knudsen, M., Marosi, K., Lu, H., Shamanna, R. A., Kalyanasundaram, S., Bollineni, R. C., Wilson, M. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.004 · Cited by 575 · see citing works
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Kam, T.-I., Mao, X., Park, H., Chou, S.-C., Karuppagounder, S. S., Umanah, G. E., Yun, S. P., Brahmachari, S., Panicker, N., Chen, R., et al. (2018) · Science · doi:10.1126/science.aat8407 · Cited by 476 · see citing works
Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos
Robinson, N., Ganesan, R., Hegedűs, C., Kovács, K. É., Kufer, T. A., & Virág, L. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101239 · Cited by 370 · see citing works
The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease
Bai, P., & Cantó, C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.016 · Cited by 312 · see citing works
Hassa, P. O., Haenni, S. S., Buerki, C., Meier, N. I., Lane, W. S., Owen, H., Gersbach, M., Imhof, R., & Hottiger, M. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507553200 · Cited by 306 · see citing works
p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1
He, Y., She, H., Zhang, T., Xu, H., Cheng, L., Yepes, M., Zhao, Y., & Mao, Z. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201701049 · Cited by 291 · see citing works
Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., Parikshak, N., Toga, A. W., Jack, C. R., Schuff, N. W., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.043 · Cited by 241 · see citing works
PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases
Martire, S., Mosca, L., & D’Erme, M. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.04.001 · Cited by 228 · see citing works
Chiarugi, A., & Moskowitz, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01684.x · Cited by 216 · see citing works
NAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208 · see citing works
Farez, M., Quintana, F., Gandhi, R., Izquierdo, G., Lucas, M., & Weiner, H. (2009) · Nature Immunology · doi:10.1038/ni.1775 · Cited by 207 · see citing works
Wang, H., Guo, W., Mitra, J., Hegde, P. M., Vandoorne, T., Eckelmann, B. J., Mitra, S., Tomkinson, A. E., Van Den Bosch, L., & Hegde, M. L. (2018) · Nature Communications · doi:10.1038/s41467-018-06111-6 · Cited by 205 · see citing works
Inhibition of Crm1–p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation
Kanai, M., Hanashiro, K., Kim, S., Hanai, S., Boulares, A. H., Miwa, M., & Fukasawa, K. (2007) · Nature Cell Biology · doi:10.1038/ncb1638 · Cited by 203 · see citing works
Vascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196 · see citing works
Rulten, S. L., Rotheray, A., Green, R. L., Grundy, G. J., Moore, D. A. Q., Gómez-Herreros, F., Hafezparast, M., & Caldecott, K. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt835 · Cited by 190 · see citing works
Anandhan, A., Jacome, M. S., Lei, S., Hernández-Franco, P., Pappa, A., Panayiotidis, M. I., Powers, R., & Franco, R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.009 · Cited by 161 · see citing works
Fu, W., Liu, Y., & Yin, H. (2019) · Stem Cells International · doi:10.1155/2019/9757201 · Cited by 159 · see citing works
Liu, T., Yang, Q., Zhang, X., Qin, R., Shan, W., Zhang, H., & Chen, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118116 · Cited by 158 · see citing works
Meng, Q., Guo, T., Li, G., Sun, S., He, S., Cheng, B., Shi, B., & Shan, A. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-018-0248-y · Cited by 152 · see citing works
The expanding field of poly(ADP‐ribosyl)ation reactions
Hakmé, A., Wong, H., Dantzer, F., & Schreiber, V. (2008) · EMBO Reports · doi:10.1038/embor.2008.191 · Cited by 148 · see citing works
Madsen, S. K., Ho, A. J., Hua, X., Saharan, P., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.002 · Cited by 144 · see citing works
Oxidative Stress in Aging-Matters of the Heart and Mind
Venkataraman, K., Khurana, S., & Tai, T. C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917897 · Cited by 143 · see citing works
Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
Sasaki, T., Liu, K., Agari, T., Yasuhara, T., Morimoto, J., Okazaki, M., Takeuchi, H., Toyoshima, A., Sasada, S., Shinko, A., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.003 · Cited by 140 · see citing works
Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians
Muiras, M.-L., Müller, M. C., Schächter, F., & Bürkle, A. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050226 · Cited by 140 · see citing works
Zhang, N., Zhang, Y., Qian, H. R., Wu, S., Cao, L., & Sun, Y. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0523-2 · Cited by 127 · see citing works
Stoica, B. A., Loane, D. J., Zhao, Z., Kabadi, S. V., Hanscom, M., Byrnes, K. R., & Faden, A. I. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.3194 · Cited by 122 · see citing works
Mangerich, A., & Bürkle, A. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/321653 · Cited by 121 · see citing works
Genome instability in Alzheimer disease
Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120 · see citing works
The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
Ke, Y., Wang, C., Zhang, J., Zhong, X., Wang, R., Zeng, X., & Ba, X. (2019) · Cells · doi:10.3390/cells8091047 · Cited by 120 · see citing works
Social hallmarks of aging: Suggestions for geroscience research
Crimmins, E. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101136 · Cited by 120 · see citing works
Yuan, Y., & Padanilam, B. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2202-5 · Cited by 119 · see citing works
Contributions of DNA Damage to Alzheimer’s Disease
Lin, X., Kapoor, A., Gu, Y., Chow, M. J., Peng, J., Zhao, K., & Tang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051666 · Cited by 117 · see citing works
PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation
Yang, Z., Li, L., Chen, L., Yuan, W., Dong, L., Zhang, Y., Wu, H., & Wang, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400359 · Cited by 114 · see citing works
Sebori, R., Kuno, A., Hosoda, R., Hayashi, T., & Horio, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9179270 · Cited by 113 · see citing works
Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β
Kauppinen, T. M., Suh, S., Higashi, Y., Berman, A. E., Escartin, C., Won, S., Wang, C., Cho, S.-H., Gan, L., & Swanson, R. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-152 · Cited by 112 · see citing works
Fischbach, A., Krüger, A., Hampp, S., Assmann, G. M., Rank, L., Hufnagel, M., Stöckl, M. T., Fischer, J. M. F., Veith, S., Rossatti, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1205 · Cited by 111 · see citing works
Hakmé, A., Wong, H., Dantzer, F., & Schreiber, V. (2008) · EMBO Reports · doi:10.1038/embor.2008.213 · Cited by 109 · see citing works
Horváth, I., Weise, C., Andersson, E. K., Chorell, E., Sellstedt, M., Bengtsson, C., Olofsson, A., Hultgren, S. J., Chapman, M. R., Wolf‐Watz, M., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209829m · Cited by 106 · see citing works
Sex differences in Alzheimer’s disease: Understanding the molecular impact
Toro, C. A., Zhang, L., Cao, J., & Cai, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.031 · Cited by 97 · see citing works
Szczęsny, B., Brunyánszki, A., Oláh, G., MITRA, S. P., & Szabó, C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1089 · Cited by 96 · see citing works
Kim, T. W., Cho, H. M., Choi, S. Y., Suguira, Y., Hayasaka, T., Setou, M., Koh, H. C., Hwang, E. M., Park, J., Kang, S. J., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.447 · Cited by 95 · see citing works
OGG1-initiated base excision repair exacerbates oxidative stress-induced parthanatos
Wang, R., Li, C., Qiao, P., Xue, Y., Zheng, X., Chen, H., Zeng, X., Liu, W., Boldogh, I. R., & Ba, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0680-0 · Cited by 94 · see citing works
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93 · see citing works
Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1
Beneke, S., Cohausz, O., Malanga, M., Boukamp, P., Althaus, F., & Bürkle, A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn615 · Cited by 88 · see citing works
Szántó, M., & Bai, P. (2020) · Genes & Development · doi:10.1101/gad.334284.119 · Cited by 88 · see citing works
Schürch, S. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21442 · Cited by 83 · see citing works
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, E. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00018 · Cited by 82 · see citing works
Nho, K. T., Corneveaux, J. J., Kim, S., Lin, H., Risacher, S. L., Shen, L., Swaminathan, S., Ramanan, V. K., Liu, Y., Foroud, T., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.24 · Cited by 81 · see citing works
Narne, P., Pandey, V., Simhadri, P. K., & Phanithi, P. B. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.007 · Cited by 80 · see citing works
Wang, Y., Lv, D.-J., Liu, W., Li, S., Chen, J., Shen, Y., Fen, W., Hu, L., & Liu, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4854732 · Cited by 79 · see citing works
Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer
Zhou, Z. G., Sun, B., Huang, S., Yu, D., & Zhang, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02794-2 · Cited by 77 · see citing works
Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria
Qian, M., Liu, Z., Peng, L., Tang, X., Meng, F., Ao, Y., Zhou, M., Wang, M., Cao, X., Qin, B., et al. (2018) · eLife · doi:10.7554/elife.34836 · Cited by 76 · see citing works
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2017) · Radiology · doi:10.1148/radiol.2017164043 · Cited by 76 · see citing works
Mao, K., Chen, J., Yu, H., Li, H., Ren, Y., Wu, X. G., Wen, Y., Zou, F., & Li, W. (2020) · Aging Cell · doi:10.1111/acel.13163 · Cited by 76 · see citing works
Self-citationTranscriptomics in Alzheimer’s Disease: Aspects and Challenges
Bagyinszky, E., Giau, V. V., & An, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103517 · Cited by 75 · see citing works
Messner, S., Schuermann, D., Altmeyer, M., Kassner, I., Schmidt, D., Schär, P., Müller, S. P., & Rottiger, M. O. (2009) · The FASEB Journal · doi:10.1096/fj.09-137695 · Cited by 73 · see citing works
Mitochondrial poly(ADP-ribose) polymerase: The Wizard of Oz at work
Brunyánszki, A., Szczęsny, B., Virág, L., & Szabó, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.024 · Cited by 73 · see citing works
Naked mole rat cells display more efficient excision repair than mouse cells
Evdokimov, A. N., Kutuzov, M. M., Petruseva, I. O., Lukjanchikova, N., Kashina, E. V., Kolova, E., Zemerova, T., Romanenko, S. A., Perelman, P. L., Prokopov, D., et al. (2018) · Aging · doi:10.18632/aging.101482 · Cited by 73 · see citing works
Rom, S., Zuluaga‐Ramirez, V., Dykstra, H., Reichenbach, N. L., Ramirez, S. H., & Persidsky, Y. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.167 · Cited by 71 · see citing works
Vuong, B., Hogan-Cann, A. D., Alano, C. C., Stevenson, M., Chan, W., Anderson, C. M., Swanson, R. A., & Kauppinen, T. M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0448-8 · Cited by 71 · see citing works
Model of human aging: Recent findings on Werner’s and Hutchinson-Gilford progeria syndromes
Ding, S.-L., & Shen, C. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1957 · Cited by 69 · see citing works
Tyagi, N., Vacek, J. C., Givvimani, S., Sen, U., & Tyagi, S. C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003614808 · Cited by 66 · see citing works
Chevanne, M., Calia, C., Zampieri, M., Cecchinelli, B., Caldini, R., Monti, D., Bucci, L., Franceschi, C., & Caiafa, P. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.0514 · Cited by 64 · see citing works
Kesäniemi, J., Lavrinienko, A., Tukalenko, E., Boratyński, Z., Kivisaari, K., Mappes, T., Milinevsky, G. P., Møller, A. P., Mousseau, T. A., & Watts, P. C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37164-8 · Cited by 63 · see citing works
Zhou, B., Yan, J., Guo, L., Zhang, B., Liu, S., Yu, M., Chen, Z., Zhang, K., Zhang, W., Li, X., et al. (2020) · Theranostics · doi:10.7150/thno.44417 · Cited by 63 · see citing works
Centrality of Early Synaptopathy in Parkinson’s Disease
Imbriani, P., Schirinzi, T., Meringolo, M., Mercuri, N. B., & Pisani, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00103 · Cited by 60 · see citing works
Nicotinamide Augments the Anti-Inflammatory Properties of Resveratrol through PARP1 Activation
Yanez, M., Jhanji, M., Murphy, K. P., Gower, R. M., Sajish, M., & Jabbarzadeh, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-46678-8 · Cited by 58 · see citing works
USP10 Is a Driver of Ubiquitinated Protein Aggregation and Aggresome Formation to Inhibit Apoptosis
Takahashi, M., Kitaura, H., Kakita, A., Kakihana, T., Katsuragi, Y., Nameta, M., Zhang, L., Iwakura, Y., Nawa, H., Higuchi, M., et al. (2018) · iScience · doi:10.1016/j.isci.2018.11.006 · Cited by 54 · see citing works
Zha, S., Li, Z., Cao, Q., Wang, F., & Liu, F. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0961-7 · Cited by 50 · see citing works
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
Yakhine-Diop, S. M. S., Morales-García, J. A., Niso-Santano, M., González-Polo, R. A., Uribe-Carretero, E., Martinez-Chacon, G., Durand, S., Maiuri, M. C., Aiastui, A., Zulaica, M., et al. (2020) · Aging · doi:10.18632/aging.103992 · Cited by 50 · see citing works
Telomere length and mortality in the Ludwigshafen Risk and Cardiovascular Health study
Pusceddu, I., Kleber, M. E., Delgado, G., Herrmann, W., März, W., & Herrmann, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198373 · Cited by 48 · see citing works
Espinoza‐Derout, J., Shao, X. M., Bankole, E., Hasan, K. M., Mtume, N., Liu, Y., Sinha‐Hikim, A. P., & Friedman, T. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00320 · Cited by 47 · see citing works
c-Abl–Mediated Tyrosine Phosphorylation of PARP1 Is Crucial for Expression of Proinflammatory Genes
Bohio, A. A., Aman, S., Wang, R., Wang, X., Sah, R. K., Guo, X., Zeng, X., Ke, Y., Boldogh, I. R., & Ba, X. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801616 · Cited by 46 · see citing works
Galindo-Campos, M. A., Bedora-Faure, M., Farrés, J., Lescale, C., Moreno-Lama, L., Martínez, C. M., Martín‐Caballero, J., Ampurdanés, C., Aparício, P., Dantzer, F., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0326-5 · Cited by 45 · see citing works
Wencel, P. L., Lukiw, W. J., Strosznajder, J. B., & Strosznajder, R. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0646-8 · Cited by 43 · see citing works
Zinc Inhibits Astrocyte Glutamate Uptake by Activation of Poly(ADP-ribose) Polymerase-1
Suh, S. W., Aoyama, K., Alano, C. C., Anderson, C. M., Hamby, A. M., & Swanson, R. A. (2007) · Molecular Medicine · doi:10.2119/2007-00043.suh · Cited by 42 · see citing works
NAD+ augmentation ameliorates acute pancreatitis through regulation of inflammasome signalling
Shen, A., Kim, H.-J., Oh, G., Lee, S.-B., Lee, S. H., Pandit, A., Khadka, D., Choe, S., Kwak, S. C., Yang, S. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03418-0 · Cited by 42 · see citing works
Lin, S., Wang, Y., Zhang, X., Kong, Q., Li, C., Li, Y., Ding, Z., & Liu, L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2586706 · Cited by 41 · see citing works
Yu, C., Kim, B., & Kim, E. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.99 · Cited by 41 · see citing works
Bütepage, M., Preisinger, C., von Kriegsheim, A., Scheufen, A., Lausberg, E., Li, J., Kappes, F., Feederle, R., Ernst, S., Eckei, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25137-w · Cited by 40 · see citing works
Ruiz, P. D., Hamilton, G. A., Park, J. W., & Gamble, M. J. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00230-19 · Cited by 40 · see citing works
Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults
McSweeney, M., Binette, A. P., Meyer, P., Gonneaud, J., Bedetti, C., Ozlen, H., Labonté, A., Rosa‐Neto, P., Breitner, J. C. S., Poirier, J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008905 · Cited by 37 · see citing works
Bickford, P. C., Flowers, A., & Grimmig, B. A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.01.027 · Cited by 36 · see citing works
The interplay between microRNAs and histone deacetylases in neurological diseases
Bourassa, M. W., & Ratan, R. R. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.03.012 · Cited by 33 · see citing works
Booth, L. A., Roberts, J. L., Samuel, P., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., Poklepovic, A. S., & Dent, P. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1436024 · Cited by 33 · see citing works
Ponce, D., Salech, F., Martin, C., Silva, M., Xiong, C., Roe, C. M., Henríquez, M., Quest, F., & Behrens, M. I. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141001113135 · Cited by 32 · see citing works
Salech, F., Ponce, D. P., SanMartín, C. D., Rogers, N. K., Chacón, C., Henríquez, M., & Behrens, M. I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00310 · Cited by 30 · see citing works
Regulated Cell Death Signaling Pathways and Marine Natural Products That Target Them
Guzmán, E. A. (2019) · Marine Drugs · doi:10.3390/md17020076 · Cited by 28 · see citing works
VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
Yun, S. P., Kim, H., Ham, S., Kwon, S., Lee, G. H., Shin, J., Lee, S. H., Ko, H. S., & Lee, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.157 · Cited by 26 · see citing works
Faraoni, I., Aloisio, F. M., Gabrieli, A. D., Consalvo, M. I., Lavorgna, S., Voso, M. T., Lo‐Coco, F., & Graziani, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.008 · Cited by 26 · see citing works
DNA-dependent SUMO modification of PARP-1
Zilio, N., Williamson, C. T., Eustermann, S., Punatar, R. S., West, S. C., Neuhaus, D., & Ulrich, H. D. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.07.001 · Cited by 23 · see citing works
Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment
Regier, M., Liang, J., Choi, A. H., Verma, K. C., Libien, J. M., & Hernandez, A. I. (2019) · Neural Plasticity · doi:10.1155/2019/4383258 · Cited by 22 · see citing works
Zanon, A., Pramstaller, P. P., Hicks, A. A., & Pichler, I. (2018) · Parkinson s Disease · doi:10.1155/2018/8684906 · Cited by 21 · see citing works
In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer’s disease
Hu, X., Dong, W., Cui, Z.-W., Gao, C., Yu, Z., Yuan, Q., & Min, Z.-L. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3696-6 · Cited by 20 · see citing works
Doaee, P., Rajaei, Z., Roghani, M., Alaei, H., & Kamalinejad, M. (2019) · PubMed Central · doi:10.22038/ajp.2019.12403 · Cited by 19 · see citing works
Hu, C., Zhao, L., Shen, M., Wu, Z., & Li, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15565 · Cited by 19 · see citing works
Molecular Crosstalk Between Circadian Rhythmicity and the Development of Neurodegenerative Disorders
Sharma, A., Lee, S., Kim, H., Yoon, H., Ha, S., & Kang, S. U. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00844 · Cited by 19 · see citing works
Kim, H., Ham, S., Lee, J. Y., Jo, A., Lee, G. H., Lee, Y., Cho, M., Shin, H., Kim, D., Pletniková, O., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21828 · Cited by 18 · see citing works
PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ
Harvey, A., Mielke, N., Grimstead, J. W., Jones, R. E., Nguyen, T., Mueller, M. R., Baird, D. M., & Hendrickson, E. A. (2018) · Oncotarget · doi:10.18632/oncotarget.26201 · Cited by 17 · see citing works
Faraoni, I., Consalvo, M. I., Aloisio, F. M., Fabiani, E., Giansanti, M., Cristino, F. D., Falconi, G., Tentori, L., Veroli, A. D., Curzi, P., et al. (2019) · Cancers · doi:10.3390/cancers11091373 · Cited by 16 · see citing works
Dysregulation of PARP1 is involved in development of Barrett’s esophagus
Zhang, C., Ma, T., Luo, T., Li, A., Gao, X., Wang, Z., & Li, F. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i9.982 · Cited by 15 · see citing works
High mobility group box-1 release from H2O2-injured hepatocytes due to sirt1 functional inhibition
Ye, T., Lu, Y., Yan, X., Hu, X., & Wang, X.-L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5434 · Cited by 13 · see citing works
Differential Localisation of PARP-1 N-Terminal Fragment in PARP-1+/+ and PARP-1−/− Murine Cells
Rajiah, I. R., & Skepper, J. N. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0077 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5
Hrubša, M., Siatka, T., Najmanová, I., Vopršalová, M., Krčmová, L. K., Matoušová, K., Javorská, L., Macáková, K., Mercolini, L., Remião, F., et al. (2022) · Nutrients · doi:10.3390/nu14030484 · Cited by 277 · see citing works
Inflammation and DNA damage: cause, effect or both
Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., & Gabrielli, A. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00905-1 · Cited by 212 · see citing works
Causes and consequences of DNA single-strand breaks
Caldecott, K. W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.11.001 · Cited by 132 · see citing works
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129 · see citing works
Que, R., Zheng, J., Chang, Z., Zhang, W., Li, H., Xie, Z., Huang, Z., Wang, H., Xu, J., Jin, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794770 · Cited by 111 · see citing works
PARP1: Liaison of Chromatin Remodeling and Transcription
Zong, W., Gong, Y., Sun, W., Li, T., & Wang, Z. (2022) · Cancers · doi:10.3390/cancers14174162 · Cited by 91 · see citing works
The threat of programmed DNA damage to neuronal genome integrity and plasticity
Caldecott, K. W., Ward, M. E., & Nussenzweig, A. (2022) · Nature Genetics · doi:10.1038/s41588-021-01001-y · Cited by 80 · see citing works
NAD+ regulates nucleotide metabolism and genomic DNA replication
Munk, S. H. N., Merchut‐Maya, J. M., Adelantado-Rubio, A., Hall, A., Pappas, G. D., Milletti, G., Lee, M., Johnsen, L. G., Guldberg, P., Bártek, J., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01280-z · Cited by 71 · see citing works
Xu, X., Sun, B., & Zhao, C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106314 · Cited by 70 · see citing works
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 67 · see citing works
DNA repair as a shared hallmark in cancer and ageing
Clarke, T. L., & Mostoslavsky, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13285 · Cited by 68 · see citing works
Liu, Y., Guttman, L. C., Dawson, V. L., & Dawson, T. M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116174 · Cited by 64 · see citing works
Sharma, A., Chabloz, S., Lapides, R. A., Roider, E., & Ewald, C. Y. (2023) · Nutrients · doi:10.3390/nu15020445 · Cited by 60 · see citing works
Reber, J. M., & Mangerich, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab618 · Cited by 57 · see citing works
A Double-Edged Sword: The Two Faces of PARylation
Kang, M., Park, S., Park, S., Lee, H. G., & Park, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179826 · Cited by 46 · see citing works
Mayor, E. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1161814 · Cited by 46 · see citing works
Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
Maggiore, A., Casale, A. M., Toscanelli, W., Cappucci, U., Rotili, D., Grieco, M., Gagné, J.-P., Poirier, G. G., d’Erme, M., & Piacentini, L. (2022) · Cells · doi:10.3390/cells11081284 · Cited by 40 · see citing works
Aghamohammad, S., Hafezi, A., & Rohani, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114816 · Cited by 40 · see citing works
Pleiotropic role of PARP1: an overview
Kumar, V., Kumar, A., Mir, K. U. I., Yadav, V., & Chauhan, S. S. (2021) · 3 Biotech · doi:10.1007/s13205-021-03038-6 · Cited by 34 · see citing works
PARP1 at the crossroad of cellular senescence and nucleolar processes
Kołacz-Milewska, K., & Robaszkiewicz, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102206 · Cited by 34 · see citing works
Johannes, J. W., Balazs, A., Barratt, D. G., Biśta, M., Chuba, M. D., Cosulich, S. C., Critchlow, S. E., Degorce, S. L., Fruscia, P. D., Edmondson, S. D., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01725 · Cited by 33 · see citing works
Jiang, Y., Uhm, H., Ip, F. C., Ouyang, L., Lo, R. M. N., Cheng, E. Y. L., Cao, X., Tan, C. M. C., Law, B. C. H., Ortiz‐Romero, P., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13676 · Cited by 36 · see citing works
Han, G., Zhen, W., Dai, Y., Yu, H., Li, D., & Ma, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.873929 · Cited by 30 · see citing works
The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases
Liu, H., Xu, S., Wang, C., Deng, Y. L., Xu, B., Yang, T., Sun, J., & Liu, W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.021 · Cited by 30 · see citing works
Mitochondria in aging and age-associated diseases.
Pahal, S., Mainali, N., Balasubramaniam, M., Reis, R. S., & Ayyadevara, S. (2025) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2025.102022 · Cited by 25 · see citing works
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
Yazar, V., Dawson, V. L., Dawson, T. M., & Kang, S.-U. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-223517 · Cited by 28 · see citing works
Endothelial dysfunction in the aging kidney
Borri, M., Jacobs, M. E., Carmeliet, P., Rabelink, T. J., & Dumas, S. J. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00287.2024 · Cited by 30 · see citing works
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
Liu, J., Duan, W., Deng, Y., Zhang, Q., Li, R., Long, J., Waqas, A., Gu, C., Qiu, Y., Cai, H., et al. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203058 · Cited by 26 · see citing works
Qian, J., Zhou, X., Tanaka, K., & Takahashi, A. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103572 · Cited by 25 · see citing works
Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
Mekhaeil, M., Dev, K. K., & Conroy, M. J. (2022) · Cancers · doi:10.3390/cancers14030687 · Cited by 25 · see citing works
Ambient particulate matter exposure causes visual dysfunction and retinal neuronal degeneration
Li, L., Song, M., Zhou, J., Sun, X., & Lei, Y. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114231 · Cited by 25 · see citing works
Zhang, H., Xie, Z., Peng, Y., Xie, A., Fu, C., Zheng, D., Cai, Z., Zhong, J., Ming, Q., Li, M., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114630 · Cited by 24 · see citing works
Yuan, P., Song, F., Zhu, P., Fan, K., Liao, Q., Huang, L., & Liu, Z. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15606 · Cited by 24 · see citing works
Shitaw, E. E., AlAhmad, M., & Sivaprasadarao, A. (2025) · Antioxidants · doi:10.3390/antiox14070776 · Cited by 26 · see citing works
Wang, Y., Pleasure, D., Deng, W., & Guo, F. (2021) · Advanced Science · doi:10.1002/advs.202102853 · Cited by 22 · see citing works
DNA damage and regulation of protein homeostasis
Paull, T. T. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103155 · Cited by 21 · see citing works
Protein modification in neurodegenerative diseases
Ramazi, S., Dadzadi, M., Darvazi, M., Seddigh, N., & Allahverdi, A. (2024) · MedComm · doi:10.1002/mco2.674 · Cited by 24 · see citing works
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
Giri, A., Mehan, S., Khan, Z., Gupta, G. D., Narula, A. S., & Kalfin, R. E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02939-y · Cited by 20 · see citing works
Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS
Tossing, G., Livernoche, R., Maios, C., Bretonneau, C., Labarre, A., & Parker, J. A. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac116 · Cited by 20 · see citing works
Mousavi, H., Rimaz, M., & Zeynizadeh, B. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00055 · Cited by 20 · see citing works
Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity
Espinar, L., García‐Cao, M., Schmidt, A., Kourtis, S., Zapater, A. G., Aranda-Vallejo, C., Ghose, R., Garcia-Lopez, L., Sheraj, I., Lorente, N. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53877-z · Cited by 19 · see citing works
Nuthikattu, S., Milenković, D., Norman, J., & Villablanca, A. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166970 · Cited by 19 · see citing works
Involvement of regulated cell deaths in aging and age-related pathologies
Torre, L. D., Beato, A., Capone, V., Carannante, D., Verrilli, G., Favale, G., Gaudio, N. D., Megchelenbrink, W., Benedetti, R., Altucci, L., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102251 · Cited by 19 · see citing works
Dent, P., Booth, L. A., Roberts, J. L., Poklepovic, A. S., Cridebring, D., & Reiman, E. M. (2021) · Aging · doi:10.18632/aging.203297 · Cited by 18 · see citing works
Ruan, C., Kong, J., He, X., Hu, B., & Zeng, X. (2022) · Food Materials Research · doi:10.48130/fmr-2022-0002 · Cited by 17 · see citing works
Thakur, A., Rana, M., Ritika, Mathew, J., Nepali, S., Pan, C.-H., Liou, J. P., & Nepali, K. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106893 · Cited by 17 · see citing works
de Lucia, C., Murphy, T., Maruszak, A., Wright, P., Powell, T. R., Hartopp, N., de Jong, S., O'Sullivan, M. J., Breen, G. D., Price, J., et al. (2021) · Aging and Disease · doi:10.14336/ad.2021.0409 · Cited by 16 · see citing works
Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms
Mohammadkhanizadeh, A., Sheibani, M., Taherkhani, S., Nourabadi, D., Mohamadi-Zarch, S.-M., Nikbakht, F., & Azizi, Y. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100189 · Cited by 16 · see citing works
Advani, D., & Kumar, P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04130-7 · Cited by 16 · see citing works
Marty, F. H., Bettamin, L., Thouard, A., Bourgade, K., Allart, S., Larrieu, G., Malnou, C. E., Gonzalez‐Dunia, D., & Suberbielle, E. (2021) · iScience · doi:10.1016/j.isci.2021.103621 · Cited by 16 · see citing works
Xie, Z., Zhang, X., Li, Y., & Zhu, R. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112913 · Cited by 16 · see citing works
Jackson, C. W., Xu, J., Escobar, I., Saul, I., Fagerli, E. A., Dave, K. R., & Pérez‐Pinzón, M. A. (2023) · Translational Stroke Research · doi:10.1007/s12975-022-01119-z · Cited by 15 · see citing works
Murata, H., Yasui, Y., Oiso, K., Ochi, T., Tomonobu, N., Yamamoto, K., Kinoshita, R., & Sakaguchi, M. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110717 · Cited by 14 · see citing works
Mathes, T. G., Monirizad, M., Ermis, M., de Barros, N. R., Rodriguez, M., Kraatz, H., Jucaud, V., Khademhosseini, A., & Falcone, N. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.05.020 · Cited by 15 · see citing works
Zhou, X., Chen, J., Patel, J. S., Ran, W., Li, Y., Van, R. S., Ibrahim, M. M. H., Zhao, C., Gao, Y., Rong, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.020 · Cited by 14 · see citing works
Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease
Ding, Y., Botchway, B. O. A., Zhang, Y., & Liu, X. (2023) · Food & Function · doi:10.1039/d2fo03484k · Cited by 13 · see citing works
NAD + depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia
Jahan, F., Vasam, G., Cariaco, Y., Nik-Akhtar, A., Green, A. E., Menzies, K. J., & Bainbridge, S. A. (2024) · Life Science Alliance · doi:10.26508/lsa.202302505 · Cited by 12 · see citing works
Sanjari‐Pour, M., Faridi, N., Wang, P., & Bathaie, S. Z. (2023) · Phytotherapy Research · doi:10.1002/ptr.7773 · Cited by 11 · see citing works
A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies
Ramesh, S., Almeida, S. D., Hammigi, S., Radhakrishna, G. K., Sireesha, G., Theivendren, P., Vellingiri, S., Kunjiappan, S., Ammunje, D. N., & Pavadai, P. (2023) · Drug Research · doi:10.1055/a-2181-0813 · Cited by 12 · see citing works
Ge, M., Hu, J., Zhou, Y., Tian, Y., Liu, Z., Yang, H., Zhou, Y., Qiu, Q., & Ye, D. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70012 · Cited by 11 · see citing works
Chaubey, S., & Singh, L. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03515-8 · Cited by 12 · see citing works
Maazouzi, M., Rasheed, M., Mbarek, L., Wang, X., Liang, J., Ma, H., Chen, Z., & Deng, Y. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70031 · Cited by 11 · see citing works
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing
Makeeva, V. S., Dyrkheeva, N. S., Lavrik, O. I., Zakian, S. M., & Malakhova, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316798 · Cited by 11 · see citing works
The brain—from neurodevelopment to neurodegeneration
Abramov, A. Y. (2022) · FEBS Journal · doi:10.1111/febs.16436 · Cited by 11 · see citing works
AlAhmad, M., Isbea, H., Shitaw, E., Li, F., & Sivaprasadarao, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66630-9 · Cited by 11 · see citing works
Application trends of hydrogen-generating nanomaterials for the treatment of ROS-related diseases
Li, X., Wang, X., Chen, G., & Tian, B. (2024) · Biomaterials Science · doi:10.1039/d4bm01450b · Cited by 10 · see citing works
Radbakhsh, S., Abrego-Guandique, D. M., Bacchetti, T., Aghaee‐Bakhtiari, S. H., Mahmoudi, A. A., Manteghi, A. A., Bazyari, M. J., Cione, E., Ferretti, G., & Sahebkar, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149607 · Cited by 10 · see citing works
Nelson, M. M., Hoff, J. D., Zeese, M. L., & Corfas, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.693595 · Cited by 10 · see citing works
Li, Y., Wang, C., Zhou, S., Shi, Y., Zhu, D., & Zheng, X. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116854 · Cited by 11 · see citing works
Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases
Tong, J., Chen, B., Tan, P. W., Kurpiewski, S., & Cai, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1062432 · Cited by 9 · see citing works
Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration
Hastings, L., Sokratian, A., Apicco, D. J., Stanhope, C. M., Smith, L., Hirst, W. D., West, A. B., & Kelly, K. (2022) · Brain Communications · doi:10.1093/braincomms/fcac042 · Cited by 8 · see citing works
Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases
Koçak, G., Dimas, M. M., Silva, L., Silva-Amaral, D., Sun, C., Cruddas, S., Barrett, T. G., Martins‐de‐Souza, D., Cunha‐Neto, E., Brocardo, P. S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695486 · Cited by 8 · see citing works
Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic frontiers
Ercin, N., Beşli, N., Beker, M., & Kılıç, Ü. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02260-y · Cited by 8 · see citing works
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors**
Ghiandoni, G. M., Flanagan, S. R., Bodkin, M. J., Nizi, M. G., Galera‐Prat, A., Brai, A., Chen, B., Wallace, J. E. A., Hristozov, D., Webster, J., et al. (2024) · Molecular Informatics · doi:10.1002/minf.202300183 · Cited by 8 · see citing works
Broken strands, broken minds: Exploring the nexus of DNA damage and neurodegeneration
Stavgiannoudaki, I., Goulielmaki, E., & Garinis, G. A. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103699 · Cited by 8 · see citing works
Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
Rana, M., Thakur, A., Kaur, C., Pan, C., Lee, S., Liou, J., & Nepali, K. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2241818 · Cited by 7 · see citing works
Varghese, N., Szabo, L., Cader, M. Z., Lejri, I., Grimm, A., & Eckert, A. (2025) · Communications Biology · doi:10.1038/s42003-025-08152-2 · Cited by 12 · see citing works
Sun, J.-Y., Wang, Z., Xu, W., & Zhao, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117050 · Cited by 7 · see citing works
From bench to bedside: Synthetic strategies and clinical application of PARP inhibitors
Man, X., Zhang, Y., He, J., Wang, P., & Qu, W. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108761 · Cited by 7 · see citing works
Gopukumar, S. T., Dwivedi, D., Gowri, K., Karpakavalli, M., Nair, C., Singh, D., & Das, U. (2025) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2025.100237 · Cited by 8 · see citing works
Dyrkheeva, N. S., Malakhova, A. A., Zakharenko, A. L., Okorokova, L. S., Shtokalo, D. N., Pavlova, S. V., Medvedev, S. P., Zakian, S. M., Nushtaeva, A. A., Tupikin, A. E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065148 · Cited by 7 · see citing works
Jia, L., Cheng, X.-Y., Ma, R., Zou, B., Zhang, Y., Wu, M.-M., Yao, Y., & Li, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06280-1 · Cited by 6 · see citing works
Xu, H. K., Wang, Q., Zhou, Y., Chen, H., Tao, J., Huang, J., Miao, Y., Zhao, J., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083900 · Cited by 6 · see citing works
Ordaz, D. A., Gupta, K., & Bota, D. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1615843 · Cited by 6 · see citing works
Precision Enzyme: Targeted Drug Discovery in Neurodegenerative Disorders
Paul, S., Tiwari, P. K., & Dubey, S. (2025) · Protein and Peptide Letters · doi:10.2174/0109298665391103250825102319 · Cited by 7 · see citing works
Pittman, M. N., Nelsen, M. B., Thompson, M. K., & Prakash, A. (2026) · Genes · doi:10.3390/genes17010082 · Cited by 6 · see citing works
Biochemical, Structural Analysis, and Docking Studies of Spiropyrazoline Derivatives
Adamus-Grabicka, A. A., Daśko, M., Hikisz, P., Kusz, J., Małecka, M., & Budzisz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116061 · Cited by 6 · see citing works
Salih, A. M., Galazzo, I. B., Petersen, S. E., Lekadir, K., Radeva, P. I., Menegaz, G., & Altmann, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277344 · Cited by 6 · see citing works
Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort
Sikosek, T., Heuvelman, M., Mika, J., Kahraman, M., Jehn, J., Frank, M., Daniel-Moreno, A., Ceiler, J., Skottke, J., Sánchez-Delgado, M., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100257 · Cited by 5 · see citing works
Connexins and blood-brain barrier: Beyond the gap
Chagnot, A., & Montagne, A. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.032 · Cited by 5 · see citing works
Dai, Y.-L., Jia, P., Zhao, Z.-M., & Gottlieb, A. (2022) · Cells · doi:10.3390/cells11142219 · Cited by 7 · see citing works
Breunig, K., Lei, X., Montalbano, M., Guardia, G. D. A., Ostadrahimi, S., Alers, V. A., Kosti, A., Chiou, J., Klein, N., Vinarov, C., et al. (2025) · eLife · doi:10.7554/elife.98152.3 · Cited by 5 · see citing works
The many connections of UFMylation with Alzheimer’s disease: a comprehensive review
Yan, T., Clarkson, B. D. S., Lou, Z., Springer, W., & Fiesel, F. C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00855-8 · Cited by 4 · see citing works
Xia, S., He, C., Li, Y., Li, H., Wang, B., Xu, L., & Zhao, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00113 · Cited by 5 · see citing works
The Central Role of Neuronal Cell Death in Alzheimer’s Disease Pathobiology
Kwak, S., Kim, J. K., Lee, Y., Baek, H. S., Kwon, Y. J., Park, M.-N., Hong, J., Lee, S.-B., Kim, H. W., & Kim, S. H. (2026) · Biomedicines · doi:10.3390/biomedicines14050953 · Cited by 5 · see citing works
Current Advances in PARP1‐Targeted Theranostics
Tong, J., Chen, B., Volpi, T., Li, Y., Ellison, P. A., & Cai, Z. (2025) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.4135 · Cited by 4 · see citing works
Chang, Y., Zhang, X., Zhang, S., & Qu, G. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03639-w · Cited by 4 · see citing works
Advances in the expression and purification of human PARP1: A user-friendly protocol
Conceição, C. J. F., Salgueiro, B. A., Ribeiro, P. A., Raposo, M., & Moe, E. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106336 · Cited by 4 · see citing works
Zhao, L., Hu, K., Liu, W.-T., Qi, H., Li, G., Chen, J., & Han, L. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.105255 · Cited by 4 · see citing works
Bai, L., Gao, Y., Li, L., Liang, Z., Qiao, Y., Wang, X., Yv, L., Yang, J., & Xu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113370 · Cited by 4 · see citing works
- Authors
- Mao, K., & Zhang, G.
- Affiliations
- Huazhong University of Science and Technology (CN)
- Corresponding author
- Zhang, Guo
- ORCID
- Zhang, Guo
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2021-02-08
- Volume
- 289
- Issue
- 8
- Pages
- 2013-2024
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W3125032790
- Cited by
- 172
- References
- 113
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 33 · 2023: 34 · 2022: 24 · 2021: 11
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (91539125, 81573146)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- PARP1, neurodegenerative diseases, aging, Alzheimer's disease, Parkinson's disease, neuroinflammation, autophagy dysregulation, mitochondrial dysfunction, SIRT1
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, Aging, Autophagy, Humans, Mitochondria, Neurodegenerative Diseases, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review